biomedicina slovenica


"CHOLESTEROL" : 801-900

  1. Rozman Damjana; Fink Martina; Majdič Gregor
    Lanosterol 14alpha-demethylase - a cholesterol biosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis
    2000
  2. Rozman Damjana
    Lanosterol 14alpha-demethylase (CYP51) - a cholesterol biosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis - a minireview
    2000
  3. Debeljak Nataša; Horvat Simon; Komel Radovan; Rozman Damjana
    Molecular cloning and partial characterization of the mouse CYP51 cDNA
    2000
  4. Kansky A
    Keratinization and psoriasis
    1999
  5. Turk Josip
    Prehrana v strategiji proti boleznim srca in ožilja
    [The role of nutrition in the strategy of cardiovascular disease prevention]
    1997
  6. Kovač-Blaž Milena; Stanič-Stefan Nataša
    Preventiva prekomerne telesne teže
    [Prevention of body overweight]
    1997
  7. Maučec-Zakotnik Jožica
    Preventiva zvišanega holesterola
    [Prevention of elevated serum cholesterol]
    1997
  8. Stanič-Stefan Nataša
    Zdravo življenje
    [Healthy life style]
    1997
  9. Debelič Olga; Lozar Sašenka
    Zdrava prehrana v bolnišnici
    [Healthy nutrition in hospital]
    1997
  10. Cevc Matija
    Novosti pri uravnavanju nizkih ravni lipoproteinov velike gostote: slovenski komentar
    1999
  11. Harper Charles R; Jacobson Terry A
    Novosti pri uravnavanju nizkih ravni lipoproteinov velike gostote
    [New perspectives on the management of low levels of high-density lipoprotein cholesterol]
    1999
  12. Rotar-Pavlič Danica
    Sekundarna preventiva ishemičnih bolezni srca - nefarmakološki pristop
    1999
  13. Žvan Bojana; Zaletel Marjan; Pečnik Borut
    The risk factors for stroke in patients with transient ischemic attacks
    1995
  14. Rozman Damjana; Fink Martina; Fimia Gian Maria; Sassone-Corsi Paolo; Waterman Michael R
    Cyclic adenosine 3',5'-monophosphate (cAMP)/cAMP - responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids
    1999
  15. Blinc Aleš
    Zdravljenje periferne arterijske okluzivne bolezni
    1998
  16. Marušič Dorjan; Marušič Andrej
    Impact of the coronary club preventive programme on risk factors for ischaemic heart disease
    1999
  17. Grad Anton
    Preprečevanje možganske kapi
    [Stroke prevention]
    1999
  18. Borovničar A; Keber I; Stavljenić-Rukavina A; Zaletel-Kragelj L
    An antioxidant influence to the arterial intima in the patients with hypercholesterolemia
    1999
  19. Filipin K; Štancar J; Šentjurc M; Pečar S
    How does the formation of cholesterol reach domains influence the distribution of tempol ester spin probes in the membrane domains of liposomes?
    1999
  20. Fink Martina; Waterman Michael R; Rozman Damjana
    Sterol-dependent and camp-dependent regulation of mammalian lanosterol 14alpha-demethylase (CYP51): cholesterol and MAS sterol production
    1999
  21. Rozman Damjana
    Sterol-dependent and cAMP-dependent regulation of lanosterol 14alpha-demethylase, an enzyme involved in cholesterol biosynthesis
    1999
  22. Kvas Andreja
    Telesna nedejavnost kot dejavnik tveganja za ishemično bolezen srca
    [Physical inactivity as a risk for ishemic heart disease]
    1999
  23. Janežič Aleksander
    Prve izkušnje z Lescolom v Sloveniji
    1995
  24. Reiner Željko; Vrbanec Damir
    Efficacy and safety of fluvastatin in hypertensive patients with hypercholesterolemia
    1995
  25. Vlckova Eva
    Fluvastatin (LESCOL, Sandoz): a new statin in the treatment of hypercholesterolaemia
    1995
  26. Keber Dušan
    Regresija ateroskleroze
    1995
  27. Bernat Nada
    Utjecaj antilipidnih tvari na aktivnost kolinesteraze u štakora
    1996
  28. Petrovič Danijel
    Molekularnogenetska analiza družinske hiperholesterolemije in koronarne bolezni
    [Molecular genetic analysis of familial hypercholesterolemia and coronary artery disease]
    1999
  29. Ekart Robert; Dvoršak Benjamin; Hojs Radovan; Gorenjak Maksimiljan
    Lipoprotein(a) pri bolnikih s končno odpovedjo ledvic, zdravljenih s kronično hemodializo
    [Lipoprotein(a) in patients with end-stage renal failure treated with maintenance hemodialysis]
    1999
  30. Pokorn Dražigost
    Vloga prehrane pri preprečevanju ateroskleroze
    [The role of nutrition in prevention of atherosclerosis]
    1999
  31. Poredoš P
    Cardiovascular disease, risk factors and physical activity in the elderly
    1998
  32. Starc V
    Beneficial physiological effects of physical activity in old age
    1998
  33. Ferlan-Marolt V; Ermenc B; Goljar J
    A huge bile granuloma mimicking a liver tumour
    1999
  34. Pavlin Rudi
    Holesterol in ateroskleroza
    [Cholesterol and atherosclerosis]
    1999
  35. Marčun-Varda Nataša
    Polimorfizem gena za angiotenzinsko konvertazo (ACE I/D) kot srčnožilni dejavnik tveganja pri otrocih
    [Angiotensin-converting enzyme gene polymorphism (ACE I/D) as cardiovascular risk factor in children]
    1999
  36. Kolbl Ignac
    Zdrava prehrana v klimakteriju
    1997
  37. Kolbl Ignac
    Hormonsko nadomestno zdravljenje inlipidi naše triletne izkušnje
    1997
  38. Planinc Melita
    Obravnava hiperholesterolemij pri moških od dvajsetega do štiridesetega leta v mabulanti ZD Krško
    1998
  39. Masten-Cuznar Olivera
    Odkrivanje in zdravljenje hiperholesterolemije v ambulanti splošne medicine pri moških starih od 36 do 65 let
    [Detection and treatment of hypercholesterolemia of men aged 36-45 in general practice]
    1996
  40. Pfeifer Marija; Verhovec Renata; Žižek Bogomir; Preželj Janez; Poredoš Pavel; Clayton Richard N
    Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
    1999
  41. Petelin Milan; Šentjurc Marjeta; Stolič Zorka; Skalerič Uroš
    EPR study of mucoadhesive ointments for delivery of liposomes into the oral mucosa
    1998
  42. Lavrenčič Aleša
    Vpliv redne telesne vadbe na fibrinolitično aktivnost krvi in endotelijsko vazodilatacijo pri bolnikih z metaboličnim kardiovaskularnim sindromom
    1999
  43. Moravec-Berger Daša; Stare Janez; Šošić Zvonko; Florjančič Mojca
    Povezanost med dejavniki tveganja in prevalenco klinično očitne ateroskleroze pri 3781 prebivalcih Slovenije
    [Relation between risk factors and prevalence of clinically manifest atherosclerosis in 3781 inhabitants of Slovenia]
    1998
  44. Prešeren-Štrukelj Metka
    Amputazione degli arti inferiori dovuta a sclerosi arteriosa
    1998
  45. Kališnik Miroslav; Vraspir-Porenta Olga; Mattfeldt Torsten
    Stereological and morphometric studies of mammalian myocardium: a review
    1998
  46. Semecky Vladimir; Gojova Andrea; Nachtigal Petr; Langrova Kamila; Beneš Viktor
    Stereological analysis of pathological changes in the blood-vessel wall after experimental induction of hypercholesterolemia
    1998
  47. Fuerst Jurij
    Preventiva bolezni srca in ožilja
    1995
  48. Keber I
    Zdravljenje hiperlipidemij
    1998
  49. Keber Irena; Lavre Simona
    Učinki pšeničnih vlaken v prehrani bolnikov s presnovnim sindromom
    1998
  50. Keber Irena
    Agresivno zniževanje ravni holesterola v krvi - ali je dovolj dokazov za tak ukrep?
    1998
  51. Malovrh Marko; Knap Bojan; Premru Vlado
    Nutritional assessment in hemodialysis patients
    [Procjena uhranjenosti hemodijaliziranih bolesnika]
    1996
  52. Rozman Damjana; Waterman Michael R
    Anthony Y. H. Lu commemorative issue: lanosterol 14 alpha-demethylase (CYP51) and spermatogenesis
    1998
  53. Lavrenčič Aleša; Fras Zlatko; Keber Irena
    Družinska hiperholesterolemija
    [Familial hypercholesterolemia]
    1999
  54. Barbič-Žagar B; Oblak D
    Vloga zdravil pri preprečevanju bolezni srca in ožilja
    1998
  55. Bulc Mateja
    Preprečevanje bolezni srca in ožilja v ambulanti splošne/družinske medicine
    1998
  56. Vene Nina
    Ateroskleroza
    1998
  57. Pavlin Rudolf; Šuput Dušan
    Ateroskleroza
    1998
  58. Pauciullo Paolo; Mancini Mario
    HDL-cholesterol - an important part of the puzzle, when we speak about coronary heart disease
    1998
  59. Pedersen Terje R
    The methuselah of clinical trials
    1998
  60. Fras Zlatko
    Life-style in prevention of coronary artery disease
    1998
  61. Turk Josip
    Introduction to the prevention of coronary artery disease
    1998
  62. Keber Irena; Škof Erik; Špan Matjaž; Štlek Mateja; Gužič Barbara
    Učinkovitost pri izvajanju sekundarne preventive po srčnem infarktu: razlike med tremi slovenskimi mesti
    [Efficacy in application of secondary preventive measures after myocardinal infarction: the differences between three Slovenian cities]
    1998
  63. Keber Dušan
    Pathophysiology of coronary atherosclerosis
    1998
  64. Kozak Matija
    Ponovna zožitev periferne arterije po nekirurškem rekanalizacijskem posegu - ocena vloge fibrinolitičnega sistema
    1998
  65. Nemec Tamara
    Vpliv sestave gojišča na metabolizem lipidov v miceliju glive Aspergillus niger
    [Influence of substrate composition on lipid metabolism in Aspergillus niger mycelium]
    1998
  66. Moravec-Berger Daša
    Utjecaj razine pojedinih čimbenika rizika na prevalenciju bolesti srca i krvožilnog sustava stanovništva Republike Slovenije
    1998
  67. Rupreht Ruth
    Uravnavanje aktivnosti HMGCoA reduktaze v sistemu semi-intaktnih celic CHO-215
    1995
  68. Keber Irena
    Holesterol, dejavnik tveganja za koronarno bolezen
    1998
  69. Petelin M; Šentjurc M; Skalerič U
    Raziskava lastnosti hidrogelov za lokalno dovajanje učinkovin na ustno sluznico
    [Study of the properties of hydrogels used for local delivery of drugs to the oral mucosa]
    1998
  70. Rozman Damjana; Fink Martina; Majdič Gregor
    Lanosterol 14alpha-demethylase - a cholesterol biosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis
    1998
  71. Poredoš Pavel; Žižek Bogomir
    Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease
    1996
  72. Jerman J; Sok M
    Is serum cholesterol a prognostik factor in lung cancer patients?
    1997
  73. Rozman D; Majdič G; Waterman MR
    Expression and role of CYP51 in mammalian germ cells
    1998
  74. Rozman D; Fink M; Stroemstedt M; Tasken K; Parvinen M; Sassone-Corsi P; Waterman MR
    Expression of lanosterol 14alpha- demethylase (CY51) in spermato-genesis: a housekeeping gene with a CAMP/CREM tau-dependent regulation
    1998
  75. Koren Igor; Panjan Jasmina
    Hilotoraks in psevdohilotoraks - prikaz primerov
    [Chylothorax and pseudochylothorax - a case report]
    1998
  76. Pokorn Dražigost
    Holesterol v jajcih
    [Choresterol in eggs]
    1998
  77. Kandus A; Kovač D; Černe D; Koselj M; Kaplan-Pavlovčič S; Buturović J; Ponikvar R; Kveder R; Lindič J; Bren AF
    Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: 3-year experience
    1998
  78. Kaplan-Pavlovčič S; Vene N; Kveder R; Vizjak A; Nagode B; Ferluga D
    Anti-neutrophil cytoplasmic antibody - associated cholesterol embolisation
    1995
  79. Stegnar Mojca; Uhrin Pavel; Peternel Polona; Mavri Alenka; Salobir-Pajnič Barbara; Stare Janez; Binder Bernd R
    The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism
    1998
  80. Lavrenčič Aleša; Kosmina Barbara; Keber Irena; Videčnik Viktor; Keber Dušan
    Carotid intima-media thickness in young patients with familial hypercholesterolaemia
    1996
  81. Stegnar M; Peternel P; Uhrin P; Cvelbar-Marinko T; Goršič-Tomažič K; Binder BR
    Fibrinolysis in patients with the 1691 G-A mutation in factor V gene and history of deep vein thrombosis
    1997
  82. Stroemstedt Maria; Waterman Michael R; Haugen Trine B; Tasken Kjetil; Parvinen Martti; Rozman Damjana
    Elevated expression of lanosterol 14 alpha-demethylase (CYP51) and the synthesis of oocyte meiosis-activating sterols in postmeiotic germ cells of male rats
    1998
  83. Barbič-Žagar Breda
    Farmakoekonomski vidiki hipolipemičnih zdravil
    [Pharmacoeconomic aspects of hypolipemic drugs]
    1998
  84. Pokorn Dražigost
    Vloga prehrane pri preprečevanju ateroskleroze
    [The role of diet in the prevention of atherosclerosis]
    1998
  85. Blinc Aleš
    Stabilna in nestabilna aterosklerotična leha
    [Stable and unstable atherosclerotic plaque]
    1998
  86. Žižek Bogomir
    Endotelijska disfunkcija in ateroskleroza
    [Endothelium dysfunction and atherosclerosis]
    1998
  87. Accetto Rok
    Arterijska hipertenzija in žile
    [Arterial hypertension and blood vessels]
    1998
  88. Zorko Tatjana
    Kajenje in razvoj ateroskleroze
    [Smoking and the development of atherosclerosis]
    1998
  89. Cevc Matija
    Pomen dislipidemije za aterosklerozo
    [The relationship between dyslipidaemias and atherosclerosis]
    1998
  90. Poredoš Pavel
    Etiopatogeneza ateroskleroze
    [Pathogenesis of atherosclerosis]
    1998
  91. Božič Mojca
    Določanje homocisteina in pojavljanje hiperhomocisteinemije pri bolnikih z vensko trombembolijsko boleznijo
    [Homocysteine determination and prevalence of hyperhomocysteinemia in patients with thromboembolic disease]
    1998
  92. Vodovnik A; Ferluga D; Vizjak A; Perković T
    Atheroembolic vasculopathy with positive antineutrophil cytoplasmic autoantibodies (ANCA) - a report of two cases
    1995
  93. Kitek Andrej
    Motnje v presnovi maščob
    1998
  94. Kaplan-Pavlovčič Staša; Vizjak Alenka; Vene Nina; Ferluga Dušan
    Antineutrophil cytoplasmic autoantibodies in atheroembolic disease
    1998
  95. Mlačak Blaž; Kapš Peter; Piletič Milivoj; Ivka Branimir
    Fibrogen, dejavniki tveganja in zastopanost periferne arterijske okluzivne bolezni pri sladkornih bolnikih
    [Fibrinogen, risk factors and prevalence of the peripheral arterial occlusive disease by diabetics]
    1998
  96. Zupan Igor
    Vpliv okolja na bolezni srca in ožilja
    1997
  97. Kveder Marina; Pifat Greta; Pečar Slavko; Schara Milan; Ramos Pilar; Esterbauer Hermann
    Nitroxide reduction with ascorbic acid in spin labeled human plasma LDL and VLDL
    1997
  98. Kveder Marina; Pifat Greta; Pečar Slavko; Schara Milan; Ramos Pilar; Esterbauer Hermann
    The interaction of lower alcohols vith apoB in spin labeled human plasma low density lipoproteins (LDL)
    1997
  99. Turk Josip
    Kardiolog o mesu
    [The cardiologist about the meat]
    1997
  100. Kočevar Klemen; Šentjurc Marjeta
    Influence of cholesterol on the structure of model lipid membranes
    1996

   1 101 201 301 401 501 601 701 801 901  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics